UTIF also sent a letter contending that Anipryl
is subject to the license agreement to DAHI in Kansas.
Veterinarians may prescribe Anipryl
(selegiline), the first FDA-approved drug to control the signs of signs of canine CDS.
It could include aspirin, anipryl
for cognitive dysfunction or anti-seizure medications.
For example, products containing amitraz (such as Certifect) should not be used on "medicated" dogs, such as those with diabetes or heart problems; amitraz, a monoamine oxidase inhibitor (MAOI), can be dangerous when combined with antidepressants (such as those used to treat separation anxiety), Anipryl
(used for canine cognitive dysfunction and Cushing's disease), and DL-Phenylalanine (DLPA), used to treat chronic pain.
The drug Anipryl
(also known as selegiline HCL or L-deprenyl), developed to treat Parkinson's disease in humans, was approved by the FDA in 1999 for use as a treatment for CCD.
(selegiline, 1-deprenyl) is the only medication approved for use in dogs to treat CCD.
Amitraz, a monoamine oxidase inhibitor (MAOI), can also be dangerous when combined with certain other drugs, including antidepressants (such as those used to treat separation anxiety), Anipryl
(used for canine cognitive dysfunction and Cushing's disease), and DL-Phenylalanine (DL PA), used to treat chronic pain in dogs.
According to Pfizer, which makes the drug, pet owners in studies reported that 69 percent to 75 percent of dogs improved in at least one clinical sign after one month of Anipryl
He was treated with Anipryl
, which was not effective, and then switched to Lysodren (mitotane).
Like all of these other drugs, it should not be combined with monoamine oxidase inhibitors (MAOls), such as selegiline (Anipryl
, l-deprenyl) and amitraz (Mitaban, also used in Preventic collars).
Amitraz can be dangerous when combined with antidepressants, such as Prozac (fluoxetine), or with other MAOl inhibitors, such as Anipryl
* L-deprenyl (Anipryl
or selegeline) is an MAO inhibitor that acts on the pituitary gland itself.